Commercial National Financial Corp. (CNAF) 23.2500 $CNAF
Commercial National Financial Corp. declares $0.26 dividend
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 4:14PM CST
Commercial National Declares $.26 Per Share First Quarter Dividend
PR Newswire - Thu Feb 12, 4:10PM CST
Commercial National Financial Corporation (OTCQB: CNAF), parent company of Commercial Bank & Trust of PA, has declared a quarterly dividend of $0.26 per share payable March 6 to shareholders of record as of February 27.
Commercial National Financial Corporation: A High-Quality Bank Selling At Discount Valuation
Yuanxi Zhang - at Seeking Alpha - Fri Jan 23, 5:00AM CST
Commercial National Financial declares $0.26 dividend
Seeking Alpha - at Seeking Alpha - Tue Nov 18, 2:00PM CST
Commercial National Declares $0.26 Per Share Fourth Quarter Dividend
PR Newswire - Tue Nov 18, 1:48PM CST
Commercial National Financial Corporation (OTCQB-CNAF), parent company of Commercial Bank & Trust of PA, has declared a quarterly dividend of $0.26 per share payable December 5 to shareholders of record as of November 28.
Commercial National Shares Commence Trading On OTCQX Marketplace
PR Newswire - Wed Sep 24, 6:00AM CDT
Commercial National Financial Corporation (OTCQX: CNAF)(Company), parent Company of Commercial Bank & Trust of PA, has qualified to trade on OTCQX®, the best marketplace.
OTC Markets Group Welcomes Commercial National Financial Corporation to OTCQX®
PR Newswire - Wed Sep 24, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced Commercial National Financial Corporation (OTCQX: CNAF), parent company of Commercial Bank & Trust of PA, has qualified to trade on OTCQX®, the best marketplace.
Commercial National Declares $0.26 Per Share Third Quarter Dividend
PR Newswire - Tue Aug 19, 3:54PM CDT
Commercial National Financial Corporation (OTCQB: CNAF), parent company of Commercial Bank & Trust of PA, has declared a quarterly dividend of $0.26 per share payable September 5 to shareholders of record as of August 29.
Commercial National Reports 22.78% Second Quarter And 33.39% First Six Months 2014 Earnings Growth
PR Newswire - Mon Jul 28, 10:05AM CDT
Commercial National Financial Corporation (OTC Markets: CNAF)(Company), parent Company of Commercial Bank & Trust of PA, has reported results for the quarter ended June 30, 2014. The Company earned $1,655,000 (or $0.58 per average share outstanding) in the second quarter 2014 compared to $1,348,000 (or $0.47 per average share outstanding) in the second quarter 2013. The Company earned $3,268,000 (or $1.14 per average share outstanding) for the six-month period ended June 30, 2014 and $2,450,000 (or $0.86 per average share outstanding) for the six-month period ended June 30, 2013. The Company's annualized return on average assets and average equity were 1.66% and 12.55%, respectively, for the quarter ended June 30, 2014 compared to 1.44% and 10.30%, respectively, for the quarter ended June 30, 2013. The Company's annualized return on average assets and average equity for the six month period ended June 30, 2014 were 1.65% and 12.39%, respectively, compared to 1.30% and 9.32%, respectively, for the six month period ended June 30, 2013. Tier one risk-based, total risk-based and leverage capital ratios for June 30, 2014 were 22.04%, 22.74% and 12.87%, respectively.
Pharmaceutical Executive, Rick Burch named President of Innovative Med Concepts, LLC
PR Newswire - Wed Feb 19, 9:53AM CST
Mr. Burch joins Innovative Med Concepts, LLC (IMC); a Biotech company based in Tuscaloosa, AL, following his most recent role as V.P. and General Manager of the CNS Business Unit for UCB, a global biopharma company based in Brussels. Prior to UCB, he had a 30-year career with pharmaceutical giant Pfizer, starting as a sales rep and working his way up to Senior Vice President overseeing several divisions as large as 6,500 people and $11.5 billion in revenue. Mr. Burch has launched over 20 pharmaceutical products with accountability for many "blockbuster" brands such as Celebrex, Lyrica, Aricept, Lipitor and Vimpat.
Commercial National Financial Corp. declares $0.26 dividend
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 4:14PM CST
Commercial National Declares $.26 Per Share First Quarter Dividend
PR Newswire - Thu Feb 12, 4:10PM CST
Commercial National Financial Corporation (OTCQB: CNAF), parent company of Commercial Bank & Trust of PA, has declared a quarterly dividend of $0.26 per share payable March 6 to shareholders of record as of February 27.
Commercial National Financial Corporation: A High-Quality Bank Selling At Discount Valuation
Yuanxi Zhang - at Seeking Alpha - Fri Jan 23, 5:00AM CST
Commercial National Financial declares $0.26 dividend
Seeking Alpha - at Seeking Alpha - Tue Nov 18, 2:00PM CST
Commercial National Declares $0.26 Per Share Fourth Quarter Dividend
PR Newswire - Tue Nov 18, 1:48PM CST
Commercial National Financial Corporation (OTCQB-CNAF), parent company of Commercial Bank & Trust of PA, has declared a quarterly dividend of $0.26 per share payable December 5 to shareholders of record as of November 28.
Commercial National Shares Commence Trading On OTCQX Marketplace
PR Newswire - Wed Sep 24, 6:00AM CDT
Commercial National Financial Corporation (OTCQX: CNAF)(Company), parent Company of Commercial Bank & Trust of PA, has qualified to trade on OTCQX®, the best marketplace.
OTC Markets Group Welcomes Commercial National Financial Corporation to OTCQX®
PR Newswire - Wed Sep 24, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced Commercial National Financial Corporation (OTCQX: CNAF), parent company of Commercial Bank & Trust of PA, has qualified to trade on OTCQX®, the best marketplace.
Commercial National Declares $0.26 Per Share Third Quarter Dividend
PR Newswire - Tue Aug 19, 3:54PM CDT
Commercial National Financial Corporation (OTCQB: CNAF), parent company of Commercial Bank & Trust of PA, has declared a quarterly dividend of $0.26 per share payable September 5 to shareholders of record as of August 29.
Commercial National Reports 22.78% Second Quarter And 33.39% First Six Months 2014 Earnings Growth
PR Newswire - Mon Jul 28, 10:05AM CDT
Commercial National Financial Corporation (OTC Markets: CNAF)(Company), parent Company of Commercial Bank & Trust of PA, has reported results for the quarter ended June 30, 2014. The Company earned $1,655,000 (or $0.58 per average share outstanding) in the second quarter 2014 compared to $1,348,000 (or $0.47 per average share outstanding) in the second quarter 2013. The Company earned $3,268,000 (or $1.14 per average share outstanding) for the six-month period ended June 30, 2014 and $2,450,000 (or $0.86 per average share outstanding) for the six-month period ended June 30, 2013. The Company's annualized return on average assets and average equity were 1.66% and 12.55%, respectively, for the quarter ended June 30, 2014 compared to 1.44% and 10.30%, respectively, for the quarter ended June 30, 2013. The Company's annualized return on average assets and average equity for the six month period ended June 30, 2014 were 1.65% and 12.39%, respectively, compared to 1.30% and 9.32%, respectively, for the six month period ended June 30, 2013. Tier one risk-based, total risk-based and leverage capital ratios for June 30, 2014 were 22.04%, 22.74% and 12.87%, respectively.
Pharmaceutical Executive, Rick Burch named President of Innovative Med Concepts, LLC
PR Newswire - Wed Feb 19, 9:53AM CST
Mr. Burch joins Innovative Med Concepts, LLC (IMC); a Biotech company based in Tuscaloosa, AL, following his most recent role as V.P. and General Manager of the CNS Business Unit for UCB, a global biopharma company based in Brussels. Prior to UCB, he had a 30-year career with pharmaceutical giant Pfizer, starting as a sales rep and working his way up to Senior Vice President overseeing several divisions as large as 6,500 people and $11.5 billion in revenue. Mr. Burch has launched over 20 pharmaceutical products with accountability for many "blockbuster" brands such as Celebrex, Lyrica, Aricept, Lipitor and Vimpat.
